BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smith DR, Holbrook MR, Gowen BB. Animal models of viral hemorrhagic fever. Antiviral Res 2014;112:59-79. [PMID: 25448088 DOI: 10.1016/j.antiviral.2014.10.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Safronetz D, Rosenke K, Westover JB, Martellaro C, Okumura A, Furuta Y, Geisbert J, Saturday G, Komeno T, Geisbert TW, Feldmann H, Gowen BB. The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset. Sci Rep 2015;5:14775. [PMID: 26456301 DOI: 10.1038/srep14775] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 9.1] [Reference Citation Analysis]
2 Stein DR, Warner BM, Audet J, Soule G, Siragam V, Sroga P, Griffin BD, Leung A, Grolla A, Tierney K, Albietz A, Kobasa D, Musa AS, Ahmad A, Akinpelu AM, Mba N, Rosenke R, Scott DP, Saturday G, Ihekweazu C, Safronetz D. Differential pathogenesis of closely related 2018 Nigerian outbreak clade III Lassa virus isolates. PLoS Pathog 2021;17:e1009966. [PMID: 34634087 DOI: 10.1371/journal.ppat.1009966] [Reference Citation Analysis]
3 Scharton D, Van Wettere AJ, Bailey KW, Vest Z, Westover JB, Siddharthan V, Gowen BB. Rift Valley fever virus infection in golden Syrian hamsters. PLoS One 2015;10:e0116722. [PMID: 25607955 DOI: 10.1371/journal.pone.0116722] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
4 Gowen BB, Naik S, Westover JB, Brown ER, Gantla VR, Fetsko A, Dagley AL, Blotter DJ, Anderson N, McCormack K, Henkel G. Potent inhibition of arenavirus infection by a novel fusion inhibitor. Antiviral Res 2021;193:105125. [PMID: 34197863 DOI: 10.1016/j.antiviral.2021.105125] [Reference Citation Analysis]
5 Li Q, Liu Q, Huang W, Wu J, Nie J, Wang M, Zhao C, Zhang L, Wang Y. An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions. Vaccine 2017;35:5172-8. [PMID: 28797730 DOI: 10.1016/j.vaccine.2017.07.101] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
6 Schönrich G, Raftery MJ. Exploring the Immunopathogenesis of Viral Hemorrhagic Fever in Mice with a Humanized Immune System. Front Immunol 2017;8:1202. [PMID: 29018450 DOI: 10.3389/fimmu.2017.01202] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
7 Cornish EF, Filipovic I, Åsenius F, Williams DJ, McDonnell T. Innate Immune Responses to Acute Viral Infection During Pregnancy. Front Immunol 2020;11:572567. [PMID: 33101294 DOI: 10.3389/fimmu.2020.572567] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
8 Warner BM. Pathogen Dose in Animal Models of Hemorrhagic Fever Virus Infections and the Potential Impact on Studies of the Immune Response. Pathogens 2021;10:275. [PMID: 33804381 DOI: 10.3390/pathogens10030275] [Reference Citation Analysis]
9 Lo Y, Perng GC. Novel concept on antiviral strategies to dengue. Current Opinion in Virology 2016;18:97-108. [DOI: 10.1016/j.coviro.2016.05.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
10 Gonzalez-Quintial R, Baccala R. Murine Models for Viral Hemorrhagic Fever. Methods Mol Biol 2018;1604:257-67. [PMID: 28986841 DOI: 10.1007/978-1-4939-6981-4_20] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
11 Prescott JB, Marzi A, Safronetz D, Robertson SJ, Feldmann H, Best SM. Immunobiology of Ebola and Lassa virus infections. Nat Rev Immunol 2017;17:195-207. [PMID: 28111475 DOI: 10.1038/nri.2016.138] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 12.2] [Reference Citation Analysis]
12 Coronel-Ruiz C, Gutiérrez-Barbosa H, Medina-Moreno S, Velandia-Romero ML, Chua JV, Castellanos JE, Zapata JC. Humanized Mice in Dengue Research: A Comparison with Other Mouse Models. Vaccines (Basel) 2020;8:E39. [PMID: 31979145 DOI: 10.3390/vaccines8010039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
13 Madrières S, Castel G, Murri S, Vulin J, Marianneau P, Charbonnel N. The Needs for Developing Experiments on Reservoirs in Hantavirus Research: Accomplishments, Challenges and Promises for the Future. Viruses 2019;11:E664. [PMID: 31331096 DOI: 10.3390/v11070664] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Idris F, Ting DHR, Alonso S. An update on dengue vaccine development, challenges, and future perspectives. Expert Opin Drug Discov 2021;16:47-58. [PMID: 32838577 DOI: 10.1080/17460441.2020.1811675] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Smither SJ, Eastaugh L, Ngugi S, O'Brien L, Phelps A, Steward J, Lever MS. Ebola Virus Makona Shows Reduced Lethality in an Immune-deficient Mouse Model. J Infect Dis 2016;214:S268-74. [PMID: 27471321 DOI: 10.1093/infdis/jiw145] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
16 Sudhakar H, Bhate J, Patra AK. Patent landscape of novel technologies for combating category-A Arenavirus infections. Expert Opin Ther Pat 2020;30:557-65. [PMID: 32274944 DOI: 10.1080/13543776.2020.1755255] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Tambunan USF, Alkaff AH, Nasution MAF, Parikesit AA, Kerami D. Screening of commercial cyclic peptide conjugated to HIV-1 Tat peptide as inhibitor of N-terminal heptad repeat glycoprotein-2 ectodomain Ebola virus through in silico analysis. J Mol Graph Model 2017;74:366-78. [PMID: 28482272 DOI: 10.1016/j.jmgm.2017.04.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 2.6] [Reference Citation Analysis]
18 Cornish JP, Moore IN, Perry DL, Lara A, Minai M, Promeneur D, Hagen KR, Virtaneva K, Paneru M, Buechler CR, O'Connor DH, Bailey AL, Cooper K, Mazur S, Bernbaum JG, Pettitt J, Jahrling PB, Kuhn JH, Johnson RF. Clinical Characterization of Host Response to Simian Hemorrhagic Fever Virus Infection in Permissive and Refractory Hosts: A Model for Determining Mechanisms of VHF Pathogenesis. Viruses 2019;11:E67. [PMID: 30650570 DOI: 10.3390/v11010067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Madelain V, Baize S, Jacquot F, Reynard S, Fizet A, Barron S, Solas C, Lacarelle B, Carbonnelle C, Mentré F, Raoul H, de Lamballerie X, Guedj J. Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies. Nat Commun 2018;9:4013. [PMID: 30275474 DOI: 10.1038/s41467-018-06215-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
20 Golden JW, Hammerbeck CD, Mucker EM, Brocato RL. Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses. Biomed Res Int 2015;2015:793257. [PMID: 26266264 DOI: 10.1155/2015/793257] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
21 Gowen BB, Westover JB, Sefing EJ, Bailey KW, Nishiyama S, Wandersee L, Scharton D, Jung KH, Ikegami T. MP-12 virus containing the clone 13 deletion in the NSs gene prevents lethal disease when administered after Rift Valley fever virus infection in hamsters. Front Microbiol 2015;6:651. [PMID: 26175722 DOI: 10.3389/fmicb.2015.00651] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
22 de Souza GAP, Rocha RP, Gonçalves RL, Ferreira CS, de Mello Silva B, de Castro RFG, Rodrigues JFV, Júnior JCVV, Malaquias LCC, Abrahão JS, Coelho LFL. Nanoparticles as Vaccines to Prevent Arbovirus Infection: A Long Road Ahead. Pathogens 2021;10:36. [PMID: 33466440 DOI: 10.3390/pathogens10010036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Misumi I, Cook KD, Mitchell JE, Lund MM, Vick SC, Lee RH, Uchimura T, Bergmeier W, Mieczkowski P, Pardo-Manuel de Villena F, Ting JPY, Whitmire JK. Identification of a Locus in Mice that Regulates the Collateral Damage and Lethality of Virus Infection. Cell Rep 2019;27:1387-1396.e5. [PMID: 31042467 DOI: 10.1016/j.celrep.2019.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]